Skip to main content
Log in
Menu
Find a journal
Publish with us
Track your research
Search
Cart
Home
Reactions Weekly
Volumes and issues
Volume 1907, Issue 1
Reactions Weekly
Publishing model
:
Subscription
Back to overview
Editorial board
Aims and scope
Search all Reactions Weekly articles
Volume 1907, Issue 1
May 2022
May 21, 2022
469 articles in this issue
Antineoplastic drugs
Case report
21 May 2022
Pages: 51 - 51
Antineoplastics
Case report
21 May 2022
Pages: 52 - 52
Antineoplastics
Case report
21 May 2022
Pages: 53 - 53
Antineoplastics
Case report
21 May 2022
Pages: 54 - 54
Antineoplastics
Case report
21 May 2022
Pages: 55 - 55
Antineoplastics
Case report
21 May 2022
Pages: 56 - 56
Antineoplastics
Case report
21 May 2022
Pages: 57 - 57
Antineoplastics
Case report
21 May 2022
Pages: 58 - 58
Antineoplastics
Case report
21 May 2022
Pages: 59 - 59
Antineoplastics
Case report
21 May 2022
Pages: 60 - 60
Antineoplastics
Case report
21 May 2022
Pages: 61 - 61
Antineoplastics
Case report
21 May 2022
Pages: 62 - 62
Antineoplastics
Case report
21 May 2022
Pages: 63 - 63
Antineoplastics
Case report
21 May 2022
Pages: 64 - 64
Antineoplastics
Case report
21 May 2022
Pages: 65 - 65
Antineoplastics
Case report
21 May 2022
Pages: 66 - 66
Antineoplastics
Case report
21 May 2022
Pages: 67 - 67
Antineoplastics/epidermal-growth-factor-receptor-antagonists
Case report
21 May 2022
Pages: 68 - 68
Antineoplastics/epirubicin
Case report
21 May 2022
Pages: 69 - 69
Antineoplastics/immunotherapies
Case report
21 May 2022
Pages: 70 - 70
Antipsoriatics
Case report
21 May 2022
Pages: 71 - 71
Antithymocyte-globulin
Case report
21 May 2022
Pages: 72 - 72
Antithymocyte-globulin/basiliximab/rituximab
Case report
21 May 2022
Pages: 73 - 73
Antivirals
Case report
21 May 2022
Pages: 74 - 74
AP-3/carboplatin/epirubicin
Case report
21 May 2022
Pages: 75 - 75
Apalutamide
Case report
21 May 2022
Pages: 76 - 76
Apixaban
Case report
21 May 2022
Pages: 77 - 77
Apixaban
Case report
21 May 2022
Pages: 78 - 78
Apremilast
Case report
21 May 2022
Pages: 79 - 79
Aspirin/clopidogrel/heparin
Case report
21 May 2022
Pages: 80 - 80
Aspirin/clopidogrel/sirolimus
Case report
21 May 2022
Pages: 81 - 81
Aspirin/clopidogrel/tirofiban
Case report
21 May 2022
Pages: 82 - 82
Aspirin/danazol/thalidomide
Case report
21 May 2022
Pages: 83 - 83
Aspirin/low-molecular-weight-heparins/sodium-citrate
Case report
21 May 2022
Pages: 84 - 84
Atezolizumab/pembrolizumab
Case report
21 May 2022
Pages: 85 - 85
Atorvastatin
Case report
21 May 2022
Pages: 86 - 86
Atropine
Case report
21 May 2022
Pages: 87 - 87
Azacitidine
Case report
21 May 2022
Pages: 88 - 88
Azathioprine/cyclophosphamide
Case report
21 May 2022
Pages: 89 - 89
Azathioprine/mesalazine/methylprednisolone
Case report
21 May 2022
Pages: 90 - 90
Azathioprine/prednisone/tacrolimus
Case report
21 May 2022
Pages: 91 - 91
Azd-1222
Case report
21 May 2022
Pages: 92 - 92
AZD-1222
Case report
21 May 2022
Pages: 93 - 93
Azd-1222
Case report
21 May 2022
Pages: 94 - 94
AZD-1222
Case report
21 May 2022
Pages: 95 - 95
Azd-1222
Case report
21 May 2022
Pages: 96 - 96
AZD-1222
Case report
21 May 2022
Pages: 97 - 97
AZD-1222
Case report
21 May 2022
Pages: 98 - 98
AZD-1222
Case report
21 May 2022
Pages: 99 - 99
AZD-1222
Case report
21 May 2022
Pages: 100 - 100
Previous
page
1
2
3
…
10
Next
page
Search
Search by keyword or author
Search
Navigation
Find a journal
Publish with us
Track your research